Harrow: California Accusation, Settlement Could Spur Other State Boards of Pharmacy to Take Action Against ImprimisRx

Published on Feb 10, 2026

Harrow (HROW), an ophthalmic drug company, announced last week that its compounding business had reached a settlement with the California Board of Pharmacy, paying a fine of $157,000 and voluntarily surrendering its state licensure in light of an August 2025 accusation from the Board. Plaintiff Anne Sodergren, executive officer of the California Board of Pharmacy, […]

Already have an account? Log in.

This article is currently locked and only available to subscribers. Request a trial to receive unlimited access to all articles.

View Only Unlocked Articles

Copyright ©2026 The Capitol Forum. All Rights Reserved.